Washington, D.C. 20549






Specialized Disclosure Report




(Exact Name of Registrant as Specified in its Charter)




Delaware   001-09585   04-2743260

(State or other jurisdiction

of incorporation)



File Number)


(IRS Employer

Identification No.)


22 Cherry Hill Drive, Danvers, Massachusetts   01923
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (978) 646-1400

Todd A. Trapp


(Name and telephone number, including area code, of the person to contact in connection with this report)



Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:


Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2017.




Section 1 — Conflict Minerals Disclosure


Item 1.01 Conflict Minerals Disclosure and Report

Conflict Minerals Disclosure

This Form SD of ABIOMED, Inc. (the “Company”) is filed pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period from January 1, 2017 to December 31, 2017.

A copy of our Conflict Minerals Report is filed herewith as Exhibit 1.01 hereto and is publicly available at:

Information appearing on is not a part of, and is not incorporated by reference into, this Form SD.


Item 1.02 Exhibit

The Company is hereby filing its Conflict Minerals Report described in Item 1.01 as Exhibit 1.01 to this Report.

Section 2 — Exhibits


Item 2.01 Exhibits

The following exhibit is filed as part of this report:

Exhibit 1.01 — Conflict Minerals Report for the calendar year ended December 31, 2017.


Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: May 24, 2018    



    By:   /s/ Todd A. Trapp
      Todd A. Trapp
      Vice President, Chief Financial Officer